Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Intangibles (2021 - 2025)

Relay Therapeutics (RLAY) has disclosed Intangibles for 5 consecutive years, with $2.3 million as the latest value for Q1 2025.

  • On a quarterly basis, Intangibles changed 0.0% to $2.3 million in Q1 2025 year-over-year; TTM through Mar 2025 was $2.3 million, a 0.0% change, with the full-year FY2024 number at $2.3 million, changed 0.0% from a year prior.
  • Intangibles was $2.3 million for Q1 2025 at Relay Therapeutics, roughly flat from $2.3 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $2.3 million in Q2 2021 to a low of $2.3 million in Q2 2021.
  • A 5-year average of $2.3 million and a median of $2.3 million in 2021 define the central range for Intangibles.
  • Biggest YoY gain for Intangibles was 0.0% in 2022; the steepest drop was 0.0% in 2022.
  • Relay Therapeutics' Intangibles stood at $2.3 million in 2021, then changed by 0.0% to $2.3 million in 2022, then changed by 0.0% to $2.3 million in 2023, then changed by 0.0% to $2.3 million in 2024, then changed by 0.0% to $2.3 million in 2025.
  • Per Business Quant, the three most recent readings for RLAY's Intangibles are $2.3 million (Q1 2025), $2.3 million (Q4 2024), and $2.3 million (Q3 2024).